Acute changes in haematocrit leading to polycythaemia in late-onset hypogonadism patients that receive testosterone replacement therapy: a South African study

References

• Dohle GR, Arver S, Bettocchi C, et al. Guidelines on male hypogonadism. European association of urology [Internet]. 2014;Feb:1–28. [cited 2014 Sep 1]. Available from: https://uroweb.org/wp-content/uploads/18-Male-Hypogonadism_LR1.pdf
   Google Scholar
• Űçer O, Gümüs B. The treatment of late-onset hypogonadism. Turk J Urol. 2014;40(3):170–179. doi: 10.5152/tud.2013.97752
   PubMedGoogle Scholar
• Davidiuk AJ, Broderick GA. Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Transl Androl Urol. 2016;5(6):824–833. doi: 10.21037/tau.2016.09.02
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;1–11. doi: 10.3109/13685538.2015.1004049
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu J, Shi X, et al. Comparing calculated free testosterone with total testosterone for screening and diagnosing late-onset hypogonadism in aged males: a cross-sectional study. J Clin Lab Anal. 2016:1–7. doi: 10.1002/jcla.22073
   Web of Science ®Google Scholar
• Shoskes JJ, Wilson MK, Spinner ML. 2016. Pharmacology of testosterone replacement therapy preparations. Transl Androl Urol. 2016;5(6):834–843. doi: 10.21037/tau.2016.07.10
   PubMed Web of Science ®Google Scholar
• Hackett GI. Testosterone replacement therapy and mortality in older men. Drug Saf. 2016;39:117–130. doi: 10.1007/s40264-015-0348-y
   PubMed Web of Science ®Google Scholar
• Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:1–20. doi: 10.1155/2012/625434
   Web of Science ®Google Scholar
• Conaglen HM, Paul RG, Yarndley RN, et al. Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice. J Sex Med. 2014;11:574–582. doi: 10.1111/jsm.12401
   PubMed Web of Science ®Google Scholar
• Basaria S. Male hypogonadism. Lancet. 2014;383(9924):1250–1263. doi: 10.1016/S0140-6736(13)61126-5
   PubMed Web of Science ®Google Scholar
• Yassin AA, Haffejee M. Testosterone depot injection in male hypogonadism: a critical appraisal. Clin Interv Aging. 2007;2(4):577–590.
   PubMed Web of Science ®Google Scholar
• Chao JH, Page ST. The current state of male hormonal contraception. Pharmacol Ther. 2016;163:109–117. doi: 10.1016/j.pharmthera.2016.03.012
   PubMed Web of Science ®Google Scholar
• Ohlander SJ, Varghese B, Pastuszak AW. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6:77–85. doi: 10.1016/j.sxmr.2017.04.001
   PubMed Web of Science ®Google Scholar
• Grech A, Breck J, Heidelbaugh J. Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Ther Adv Drug Saf. 2014;5(5):190–200. doi: 10.1177/2042098614548680
   PubMedGoogle Scholar
• Coviello A, Kaplan B, Lakshman K, et al. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008;93(3):914–919. doi: 10.1210/jc.2007-1692
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Maseroli E, et al. Testosterone replacement therapy and cardiovascular risk: a review. World J Mens Health 2015;33(3):130–142. doi: 10.5534/wjmh.2015.33.3.130
   PubMedGoogle Scholar
• Monthly index of medical specialities (MIMS). Rosebank: Times Media; 2016 May. 56(4):359.
   Google Scholar
• Jones SD, Dukovac T, Sangkum P, et al. Erythrocytosis and polycythemia secondary to testosterone replacement therapy in the aging male. Sex Med Rev. 2015;3:101–112. doi: 10.1002/smrj.43
   PubMedGoogle Scholar
• Zitzmann M, Mattern A, Hanisch J, et al. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men. J Sex Med. 2013;10:579–588. doi: 10.1111/j.1743-6109.2012.02853.x
   PubMed Web of Science ®Google Scholar
• Haider A, Gooren L, Padungtod P, et al. A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months. Andrologia. 2010;42:349–355. doi: 10.1111/j.1439-0272.2009.01016.x
   PubMed Web of Science ®Google Scholar
• Golden C. Polycythemia vera: a review. Clin J Oncol Nurs. 2003;7(5):553–556. doi: 10.1188/03.CJON.553-556
   PubMedGoogle Scholar
• Khera M, Broderick GA, Carson III, et al. Adult-onset hypogonadism. Mayo Clin Proc. 2016;91(7):908–926.
   Google Scholar
• Assi TB, Baz E. Current applications of therapeutic phlebotomy. Blood Transfus. 2014;12(1):s75–s83.
   PubMedGoogle Scholar